By Kiran Mazumdar-Shaw Over the last 20 years, life sciences in India has gone from being a nascent sector to a sunrise industry. When I began my own entrepreneurial journey in 1978, little did I know that I was sowing the seeds of the country’s biotechnology revolution. Up until the mid-1980s, I was the lone … Continue reading India’s Life Sciences Industry Poised for the Next Level
The Pandemic has Unleashed Opportunities We Never Thought Existed
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics The tectonic shifts that the COVID-19 pandemic brought with it has thrust the Indian biotechnology industry into the global limelight. The industry responded with grit, agility and creativity to address India’s healthcare needs in the face of a rampaging viral outbreak. This global emergency galvanized India’s … Continue reading The Pandemic has Unleashed Opportunities We Never Thought Existed
A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw
Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading A game-changing, transformational deal that is an inflection point in Biocon Biologic’s journey of making global impact: Kiran Mazumdar-Shaw
The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League
Biocon Biologics on Monday announced a transformational deal to acquire partner Viatris’ global biosimilars business for up to USD 3.335 billion in cash and stock. The acquisition of the business, which is estimated to generate revenues of USD 1 billion next year, will create a unique, fully integrated global biosimilars enterprise. Kiran Mazumdar-Shaw, Executive Chairperson, … Continue reading The Biocon Biologics-Viatris Transaction Catapults us into The Global Big League
Budget: Taking Strides Towards Digital Health
By Kiran Mazumdar-Shaw It was very heartening to see a Budget empathize with those who had to bear adverse health effects of the pandemic. The wide coverage of our nation’s vaccination drive greatly helped amidst the 3rd wave of the pandemic caused by the Omicron variant, resulting in milder symptoms. Even though India is in … Continue reading Budget: Taking Strides Towards Digital Health
A Fair Budget that Balances the Needs of the Indian Economy
By Kiran Mazumdar-Shaw Finance Minister Nirmala Sitharaman has presented the nation with a balanced Budget for FY23. The Indian economy needs a steadying hand at a time when it is trying to find its feet as the tremors from the global COVID-19 pandemic recede slowly. She has prudently laid the groundwork for a gradual economic … Continue reading A Fair Budget that Balances the Needs of the Indian Economy
A Balanced Budget
By Kiran Mazumdar Shaw, Chairperson, Biocon Finance Minister Nirmala Sitharaman has delivered a Budget that ticks several boxes. The Budget focused on maintaining fiscal prudence, improving ease of doing business, boosting infrastructure, and creating a strong digital governance architecture. The economic gloom caused by the Covid-19 pandemic had raised expectations of a ‘feel good’ budget. … Continue reading A Balanced Budget
HOPE FM DELIVERS A FEEL-GOOD BUDGET
By Kiran Mazumdar-Shaw The Covid-19 pandemic has cast a gloomy outlook across the entire economy. Government coffers are depleting, Industry investments are shrinking, and citizens are being hit by inflation and job losses. Budget 2022 is an event that everyone is hoping will deliver good news and I wish the Finance Minister will not dash our hopes! … Continue reading HOPE FM DELIVERS A FEEL-GOOD BUDGET
Technology holds huge promise for healthcare in India in 2022
By Kiran Mazumdar-Shaw The COVID-19 pandemic has caused a digital disruption in healthcare. It has accelerated innovation, catalysed technological breakthroughs, and created a fertile environment for the emergence of low-cost innovations anchored in affordability, and accessibility. It has also forced changes in consumer behaviour, persuaded doctors to become tech-savvy, prompted pharma companies to invest in … Continue reading Technology holds huge promise for healthcare in India in 2022
Kiran Mazumdar-Shaw’s Statement on John Shaw’s Offshore Trust
Notification to Stock Exchanges October 4, 2021 I would like to explain the situation relating to certain media reports on Pandora Papers which have referred to my husband John Shaw’s Offshore trust. I would like to state that these stories have grossly misrepresented the facts. I would therefore like to present the facts to you … Continue reading Kiran Mazumdar-Shaw’s Statement on John Shaw’s Offshore Trust